Literature DB >> 2443536

Gray platelet syndrome. Demonstration of alpha granule membranes that can fuse with the cell surface.

J P Rosa1, J N George, D F Bainton, A T Nurden, J P Caen, R P McEver.   

Abstract

Platelets from patients with the gray platelet syndrome have decreased recognizable alpha granules and are markedly deficient in some alpha-granule secretory proteins. Using immunocytochemical techniques with antibodies to an alpha-granule membrane protein, GMP-140, we identified the membranes of intracellular vesicles in gray platelets as alpha-granule membranes. Gray platelets contained normal amounts of GMP-140 as measured by electroimmunoassay. The activation of gray platelets with thrombin caused GMP-140 to be redistributed to the plasma membrane surface, as in normal platelets. In agreement with previous studies, an endogenously synthesized secretory protein, platelet factor 4, was undetectable in gray platelets. However, the alpha-granule proteins albumin and IgG, which are thought to be derived from endocytosis of plasma proteins into megakaryocytes, were present in substantial quantities and were secreted efficiently from gray platelets. Therefore, the fundamental defect in the gray platelet syndrome may be in the targeting of endogenously synthesized secretory proteins to developing alpha granules in megakaryocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443536      PMCID: PMC442357          DOI: 10.1172/JCI113171

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: an immunogold-surface replica study.

Authors:  W M Isenberg; R P McEver; M A Shuman; D F Bainton
Journal:  Blood Cells       Date:  1986

2.  Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins.

Authors:  V L Woods; L E Wolff; D M Keller
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

3.  Incorporation of a circulating protein into megakaryocyte and platelet granules.

Authors:  P J Handagama; J N George; M A Shuman; R P McEver; D F Bainton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  Development of a radioimmunoassay for human platelet factor 4.

Authors:  S P Levine; L S Krentz
Journal:  Thromb Res       Date:  1977-11       Impact factor: 3.944

5.  Gray platelet syndrome. A variety of qualitative platelet disorder.

Authors:  G Raccuglia
Journal:  Am J Med       Date:  1971-12       Impact factor: 4.965

6.  Cell-type-specific fibronectin subunits generated by alternative splicing.

Authors:  J I Paul; J E Schwarzbauer; J W Tamkun; R O Hynes
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

7.  Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes.

Authors:  R Nachman; R Levine; E A Jaffe
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

8.  A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein.

Authors:  C L Berman; E L Yeo; J D Wencel-Drake; B C Furie; M H Ginsberg; B Furie
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

9.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

Authors:  J N George; E B Pickett; S Saucerman; R P McEver; T J Kunicki; N Kieffer; P J Newman
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

10.  Immunohistochemical localization of membrane and alpha-granule proteins in plastic-embedded mouse bone marrow megakaryocytes and murine megakaryocyte colonies.

Authors:  P E Stenberg; J H Beckstead; R P McEver; J Levin
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

View more
  15 in total

1.  Pseudo gray platelet syndrome in a patient with acute myocardial infarction.

Authors:  Shigeo Toyota; Norihiko Nakamura; Kazuo Dan
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

Review 2.  [Congenital thrombocytopathies].

Authors:  C M Kirchmaier; D Pillitteri
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

3.  Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p.

Authors:  Meral Gunay-Aygun; Yifat Zivony-Elboum; Fatma Gumruk; Dan Geiger; Mualla Cetin; Morad Khayat; Robert Kleta; Nehama Kfir; Yair Anikster; Judith Chezar; Mauricio Arcos-Burgos; Adel Shalata; Horia Stanescu; Joseph Manaster; Mutlu Arat; Hailey Edwards; Andrew S Freiberg; P Suzanne Hart; Lauren C Riney; Katherine Patzel; Pranoot Tanpaiboon; Tom Markello; Marjan Huizing; Irina Maric; McDonald Horne; Beate E Kehrel; Kerstin Jurk; Nancy F Hansen; Praveen F Cherukuri; Marypat Jones; Pedro Cruz; Jim C Mullikin; Alan Nurden; James G White; William A Gahl; Tzippora Falik-Zaccai
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

4.  Platelets of the Wistar Furth rat have reduced levels of alpha-granule proteins. An animal model resembling gray platelet syndrome.

Authors:  C W Jackson; N K Hutson; S A Steward; N Saito; E M Cramer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

5.  Gray platelet syndrome. Dissociation between abnormal sorting in megakaryocyte alpha-granules and normal sorting in Weibel-Palade bodies of endothelial cells.

Authors:  J Gebrane-Younès; E M Cramer; L Orcel; J P Caen
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  The origin of the membrane convolute in degranulating platelets. A comparative study of normal and "gray" platelets.

Authors:  E Morgenstern; H Patscheke; G Mathieu
Journal:  Blut       Date:  1990-01

7.  The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis.

Authors:  Denisa Urban; Ling Li; Hilary Christensen; Fred G Pluthero; Shao Zun Chen; Michael Puhacz; Parvesh M Garg; Kiran K Lanka; James J Cummings; Helmut Kramer; James D Wasmuth; John Parkinson; Walter H A Kahr
Journal:  Blood       Date:  2012-09-21       Impact factor: 22.113

8.  Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice.

Authors:  Carsten Deppermann; Deya Cherpokova; Paquita Nurden; Jan-Niklas Schulz; Ina Thielmann; Peter Kraft; Timo Vögtle; Christoph Kleinschnitz; Sebastian Dütting; Georg Krohne; Sabine A Eming; Alan T Nurden; Beate Eckes; Guido Stoll; David Stegner; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

9.  Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice.

Authors:  Walter H A Kahr; Richard W Lo; Ling Li; Fred G Pluthero; Hilary Christensen; Ran Ni; Nima Vaezzadeh; Cynthia E Hawkins; Andrew S Weyrich; Jorge Di Paola; Carolina Landolt-Marticorena; Peter L Gross
Journal:  Blood       Date:  2013-07-16       Impact factor: 22.113

10.  Phenotypic heterogeneity in the Gray platelet syndrome extends to the expression of TREM family member, TLT-1.

Authors:  Alan T Nurden; Paquita Nurden; Emilsé Bermejo; Robert Combrié; Daniel W McVicar; A Valance Washington
Journal:  Thromb Haemost       Date:  2008-07       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.